Sclar Jeremy M. bought PMN

October 11, 2022 · Form 4 insider transaction

Sclar Jeremy M. bought 26,217 shares of ProMIS Neurosciences, Inc., a transaction worth N/A. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 448 days after the transaction.

Direction
Acquired (buy-side)
Shares
26,217
Price
N/A
Total value
N/A
Role
SecurityWarrants to Purchase Common Shares, no par value
Transaction codeP: Open-market purchase
Transaction dateOctober 11, 2022
Filing dateJanuary 2, 2024
Shares owned after26,217
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

Consists of 26,217 warrants to purchase Common Shares, each exercisable to purchase one Common Share at an exercise price of $7.50 per whole warrant. These warrants are part of Units, each consisting of one Common Share and one-quarter of one warrant to purchase one Common Share. The purchase price for each Unit was $5.40. These warrants are currently exercisable and expire on April 11, 2028, the fifth anniversary of the date the warrants first become exercisable. These warrants were inadvertently omitted from Mr. Sclar's Form 3 filed on September 5, 2023.; Held through the Jeremy M. Sclar 2012 Irrevocable Family Trust, a trust formed under a trust instrument governed by the laws of the Commonwealth of Massachusetts ("JS Trust"). Mr Sclar's spouse is one of the trustees of the JS Trust.

View the original Form 4 on SEC EDGAR